AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results

Stock Information for Anixa Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Anixa Biosciences Inc.

AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism
AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results
AngioDynamics to Host Virtual Cardiovascular Investor Event
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife(TM) System

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.